4chromanone

4-Chromanone, with CAS No. 491-37-2, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. 4-Chromanone provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

6-Fluorothio-4-chromanone ,with CAS No. 21243-18-5, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. 6-Fluorothio-4-chromanone provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

6-Methyl-4-chromanone ,with CAS No. 39513-75-2, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. 6-Methyl-4-chromanone provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

6-Fluoro-4-chromanone ,with CAS No. 66892-34-0, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. 6-Fluoro-4-chromanone provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

Flavanone (2-Phenylchroman-4-one)s from citrus fruits have also been shown to exert beneficial effects on human vascular function. In particular, chronic interventions with orange juice, or the pure flavanone hesperidin, resulted in a decrease in blood pressure in overweight volunteers and acute improvements in microvascular reactivity.

6-methoxy-4-chromanone, with CAS No. 5802-17-5, is a fragment molecule that serves as an important scaffold for molecular linking, expansion, and modification. 6-methoxy-4-chromanone provides a structural basis and research tool for the design and screening of novel drug candidates, and is commonly used in drug discovery, drug synthesis, and related research.

(R)-(4′-Hydroxy)-5,7-dihydroxy-4-chromanone, an antiangiogenic homoisoflavonoid, exhibits activity against human retinal microvascular endothelial cells (HRMECs).